Re: Pyrotinib versus placebo in combination with trastuzumab and docetaxel as first line treatment in patients with HER2 positive metastatic breast cancer (PHILA): randomised, double blind, multicentre, phase 3 trial
(Source: BMJ Comments)
Source: BMJ Comments - November 12, 2023 Category: General Medicine Source Type: forums

cT1N0 breast cancer. RNI?
65 yo cT1N0 ER/PR- HER2+ with NA taxol/herceptin. s/p lumpectomy and SLNB, ypT1N1 with 4 mm focus of residual disease in the node. Had she been cT1N1 and ypT1N1 I'd do RNI. Had she been cT1N0 and pT1N1, I'd probably just do WBRT. Wondering if there's a way to not do RNI here. (Source: Student Doctor Network)
Source: Student Doctor Network - December 28, 2020 Category: Universities & Medical Training Authors: Ray D. Ayshun Tags: Radiation Oncology Source Type: forums

Re: NICE approves trastuzumab emtansine after deal with drug company
(Source: BMJ Comments)
Source: BMJ Comments - June 17, 2017 Category: General Medicine Source Type: forums